학술논문
PERK inhibitor, GSK2606414, ameliorates neuropathological damage, memory and motor functional impairments in cerebral ischemia via PERK/p-eIF2ɑ/ATF4/CHOP signaling
Document Type
Article
Author
Source
In: Metabolic Brain Disease . (Metabolic Brain Disease, April 2023, 38(4):1177-1192)
Subject
Language
English
ISSN
15737365
08857490
08857490